Thoma Bravo, LLC, a leading private equity investment firm is certainly investing in the future with its latest acquisition of Imprivata® (NYSE: IMPR), a Massachusetts-based healthcare IT security company.

Imprivata®’s technology enables healthcare organizations worldwide to access, communicate and transact patient information securely while also addressing critical compliance and security challenges. Thoma Bravo paid approximately $544 million for the company.

As healthcare continues to go paperless, the need for strong and compliant security technology coupled with ease of access will only continue to grow.